Diabetes drugs ride a bumpy road

Nature. 2013 Dec 12;504(7479):198. doi: 10.1038/504198a.
No abstract available

Publication types

  • News

MeSH terms

  • Benzhydryl Compounds
  • Blood Glucose / analysis
  • Clinical Trials as Topic
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / epidemiology
  • Glucosides / adverse effects
  • Glucosides / pharmacology
  • Glucosides / therapeutic use
  • Heart Diseases / chemically induced
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use
  • Sodium-Glucose Transporter 2 / metabolism
  • Sodium-Glucose Transporter 2 Inhibitors*
  • Weight Loss / drug effects

Substances

  • Benzhydryl Compounds
  • Blood Glucose
  • Glucosides
  • Hypoglycemic Agents
  • SLC5A2 protein, human
  • Sodium-Glucose Transporter 2
  • Sodium-Glucose Transporter 2 Inhibitors
  • dapagliflozin